Literature DB >> 8406764

Application of dexamethasone in the treatment of acute spinal cord injury.

J E Kiwerski1.   

Abstract

This communication evaluates the clinical efficacy of dexamethasone in acute spinal cord injury. The results of treatment in 290 patients given dexamethasone were compared with those of the control group of 330 patients not treated with corticosteroids. Patients with complete injuries and those with incomplete injuries showed greater improvement both quantitatively and qualitatively after treatment with dexamethasone than those without corticosteroids. The slightly increased risk of complications such as gastrointestinal bleeding and delayed wound healing was noted. It is recommended that corticosteroids should be used within the first hours after spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406764     DOI: 10.1016/0020-1383(93)90149-z

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  11 in total

Review 1.  Glucocorticoids and central nervous system inflammation.

Authors:  Klaus Dinkel; William O Ogle; Robert M Sapolsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  Chemical priming for spinal cord injury: a review of the literature part II-potential therapeutics.

Authors:  Martin M Mortazavi; Ketan Verma; Aman Deep; Fatemeh B Esfahani; Patrick R Pritchard; R Shane Tubbs; Nicholas Theodore
Journal:  Childs Nerv Syst       Date:  2010-12-21       Impact factor: 1.475

Review 3.  Chemical priming for spinal cord injury: a review of the literature. Part I-factors involved.

Authors:  Martin M Mortazavi; Ketan Verma; Aman Deep; Fatemeh B Esfahani; Patrick R Pritchard; R Shane Tubbs; Nicholas Theodore
Journal:  Childs Nerv Syst       Date:  2010-12-18       Impact factor: 1.475

4.  Somatosensory spinal cord evoked potentials in the evaluation of the effect of dexamethasone in experimental spinal cord injury.

Authors:  O Güney; O Acar; O Demir; M E Ustün; Y Kocaoğullar
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

5.  Pregabalin as a neuroprotector after spinal cord injury in rats.

Authors:  Kee-Yong Ha; Young-Hoon Kim; Kee-Won Rhyu; Soon-Eok Kwon
Journal:  Eur Spine J       Date:  2008-03-20       Impact factor: 3.134

6.  Effective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicelles.

Authors:  YueLong Wang; Min Wu; Lei Gu; XiaoLing Li; Jun He; LiangXue Zhou; Aiping Tong; Juan Shi; HongYan Zhu; JianGuo Xu; Gang Guo
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.

Authors:  Nathan Evaniew; Vanessa K Noonan; Nader Fallah; Brian K Kwon; Carly S Rivers; Henry Ahn; Christopher S Bailey; Sean D Christie; Daryl R Fourney; R John Hurlbert; A G Linassi; Michael G Fehlings; Marcel F Dvorak
Journal:  J Neurotrauma       Date:  2015-07-17       Impact factor: 5.269

Review 8.  The safety and efficacy of steroid treatment for acute spinal cord injury: A Systematic Review and meta-analysis.

Authors:  Ihtisham Sultan; Nayan Lamba; Aaron Liew; Phoung Doung; Ishaan Tewarie; James J Amamoo; Laxmi Gannu; Shreya Chawla; Joanne Doucette; Christian D Cerecedo-Lopez; Stefania Papatheodorou; Ian Tafel; Linda S Aglio; Timothy R Smith; Hasan Zaidi; Rania A Mekary
Journal:  Heliyon       Date:  2020-02-19

Review 9.  Recent Findings on the Effects of Pharmacological Agents on the Nerve Regeneration after Peripheral Nerve Injury.

Authors:  Samira Bolandghamat; Morteza Behnam-Rassouli
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

10.  The Aging Population Faces Increased Risk for Musculoskeletal Pathologies: The Problematic Atlas-Axis Instability.

Authors:  Antonia Nituleasa; Elizabeth D Liu; Ryan F Amidon; Christ Ordookhanian; Paul Kaloostian
Journal:  Cureus       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.